Open Accessibility Menu

Coronavirus (COVID-19) Vaccine Update Click here to learn more.

For information about COVID-19 or to view additional resources, please click here.

Divya Shankaranarayanan

GW Provider
Need an Appointment ?
Contact (202) 741-3333
Divya Shankaranarayanan Divya Shankaranarayanan


  • Assistant Professor of Medicine
Medical Biography
Clinical Interests
  • Precision immunosuppression for transplantation
  • Management of rejection in transplant patients
  • COVID-related kidney disease
  • Medical School
    • MBBS - Kilpauk Medical College, India
  • Residency
    • Louisiana State University at Lafayette - Internal Medicine
  • Fellowship
    • Weill Cornell Medicine - Nephrology
    • Weill Cornell Medicine - Transplantation Medicine
Board Certified
  • Internal Medicine
  • Nephrology

Divya Shankaranarayanan MD is an Assistant Professor of Medicine in the division of Kidney Diseases and Hypertension at the George Washington University School of Medicine & Health Sciences. She is board certified in Internal Medicine, Nephrology and completed training in Transplantation Medicine recognized by the American Society of Transplantation.  

Dr. Shankaranarayanan received her MBBS degree from Kilpauk Medical College, India. She completed her Internal Medicine residency from Louisiana State University at Lafayette. She did a fellowship training in Nephrology, followed by another fellowship in Transplantation Medicine from Weill Cornell Medicine, New York under the mentorship of Dr. Manikkam Suthanthiran. 

Her clinical interests include precision immunosuppression for transplantation, management of  rejection in transplant patients and COVID related kidney disease.  

Her research interests include studying the mechanisms of normal human immunology, transplantation immunology and urine transcriptomics. She has worked on the role of calcium release (CRAC) channel inhibitors on normal human peripheral blood mononuclear cells in Suthanthiran laboratory.  She has several publications in high impact journals in topics ranging from urinary cell transcriptomics in acute rejection to dialysis in COVID-19 patients.